Condition
Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Malignancies clinical trials that are recruiting, at sites in 3 countries (most in China (2), Thailand (1), Italy (1)). By phase: Early Phase 1 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Malignancies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HSCT outcomes in children at Ramathibodi Hospital | — | Ratchathewi, Bangkok | Recruiting | Oct 5, 2026 |
| JL19001 Injection Alone or with Standard Therapy in Advanced Solid Tumors or Relapsed/Refractory B-Cell NHL | Phase 1 | Beijing, Beijing Municipality | Recruiting | May 22, 2026 |
| IASO207 Injection for relapsed or refractory B-cell cancers | Early Phase 1 | Beijing | Recruiting | May 7, 2026 |
| Metformin added to temozolomide for newly diagnosed IDH-wildtype glioblastoma | Phase 2 | Milan | Recruiting | Jul 3, 2023 |
All recruiting trials (4)
-
HSCT outcomes in children at Ramathibodi Hospital
This study tests how hematopoietic stem cell transplantation works in pediatric patients with blood diseases, cancers, and other conditions at Ramathibodi Hospital.
-
JL19001 Injection Alone or with Standard Therapy in Advanced Solid Tumors or Relapsed/Refractory B-Cell NHL
This phase 1 trial tests JL19001 by itself or with standard treatment to see if it is safe and tolerable in adults with advanced solid tumors or relapsed/refractory B-cell non-Hodgkin lymphoma.
-
IASO207 Injection for relapsed or refractory B-cell cancers
This early, single-center study tests IASO207 injections to see if they are safe and potentially beneficial for adults with relapsed or refractory B-cell malignancies who have not responded to standard therapies.
-
Metformin added to temozolomide for newly diagnosed IDH-wildtype glioblastoma
This Phase 2 trial will test if adding metformin to standard temozolomide helps adults with newly diagnosed IDH-wildtype glioblastoma.
Related topics
Quick answers
How many Malignancies clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Thailand (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.